Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. The Company's medicines are helping numerous patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.
Type
Public
HQ
New York, US
Founded
1887
Size (employees)
23,700 (est)-5%
Website
bms.com
Bristol-Myers Squibb was founded in 1887 and is headquartered in New York, US
Report incorrect company information

Key People/Management at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chief Executive Officer
Charles Bancroft

Charles Bancroft

Executive Vice President, CFO
Francis Cuss

Francis Cuss

Executive Vice President and Chief Scientific Officer
Lamberto Andreotti

Lamberto Andreotti

Chairman, Board of Directors

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in Zug, BI, Lawrence Township, Devens and in 176 other locations
New York, US (HQ)
345 Park Avenue
Show all (181)
Report incorrect company information

Bristol-Myers Squibb Financials and Metrics

Bristol-Myers Squibb Financials

Bristol-Myers Squibb's revenue was reported to be $19.43 b in FY, 2016 which is a 17.3% increase from the previous period.
USD

Revenue (Q3, 2017)

5.3 b

Gross profit (Q3, 2017)

3.7 b

Gross profit margin (Q3, 2017), %

70.1%

Net income (Q3, 2017)

856 m

Market capitalization (23-Apr-2018)

83.7 b

Cash (30-Sep-2017)

4.6 b

EV

86.1 b
Bristol-Myers Squibb's current market capitalization is $83.7 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

16.4 b15.9 b16.6 b19.4 b

Revenue growth, %

(3%)4%17%

Cost of goods sold

4.6 b3.9 b3.9 b4.9 b

Gross profit

11.8 b11.9 b12.7 b14.5 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

4.1 b3.8 b3.9 b3.9 b4 b4.2 b4.1 b4.4 b4.9 b4.9 b4.9 b5.1 b5.3 b

Cost of goods sold

1.2 b968 m991 m1 b847 m1 b1.1 b1.1 b1.2 b1.3 b1.3 b1.6 b1.6 b

Gross profit

2.9 b2.8 b2.9 b2.9 b3.2 b3.2 b3 b3.3 b3.7 b3.6 b3.7 b3.6 b3.7 b

Gross profit Margin, %

71%75%75%74%79%76%73%76%75%73%74%70%70%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.6 b5.6 b2.4 b4.2 b

Inventories

1.5 b1.6 b1.2 b1.2 b

Current Assets

18.9 b14.6 b10.4 b13.7 b

Goodwill

7.1 b7 b6.9 b6.9 b
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

4.2 b4 b2.6 b2.9 b3.4 b3.9 b3.5 b4.6 b

Inventories

1.3 b1.1 b1.3 b1.4 b1.5 b1.4 b1.2 b1.3 b

Current Assets

13.1 b12.9 b11.2 b12.3 b13.2 b13.6 b14.3 b15 b

Goodwill

7 b7 b6.9 b6.9 b6.9 b6.9 b6.9 b6.9 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2 b1.6 b4.5 b

Inventories

(45 m)(254 m)97 m(152 m)

Accounts Payable

412 m(44 m)(919 m)104 m

Cash From Operating Activities

3.5 b3.1 b1.8 b2.9 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

1.8 b936 m1.3 b2 b1.2 b1.1 b1.8 b1.2 b2.4 b3.6 b1.5 b2.4 b3.3 b

Inventories

(8 m)(144 m)(157 m)(162 m)51 m162 m231 m(44 m)(111 m)(107 m)(71 m)(58 m)7 m

Accounts Payable

301 m(12 m)(112 m)63 m(83 m)(618 m)(1.2 b)(77 m)(36 m)(142 m)(114 m)(85 m)63 m

Cash From Operating Activities

2.1 b1.7 b2.6 b626 m697 m1.2 b25 m1.4 b2.4 b4.2 b
USDY, 2017

EV/CFO

20.7 x

EV/FCF

25.6 x

Revenue/Employee

210.2 k

Financial Leverage

2.3 x
Show all financial metrics

Bristol-Myers Squibb Operating Metrics

Y, 2015Y, 2016

Phase III Trials Products

2 8

Projects in R&D Pipeline

32 44
Show all operating metrics
Report incorrect company information